The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics

被引：15
|
作者：
Wautlet, A. [1 ]
Bachert, C. [2 ,3 ,4 ]
Desrosiers, M. [5 ]
Hellings, Peter W. [6 ,7 ]
Peters, Anju T. [1 ,8 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60610 USA
[2] Univ Hosp Munster, Dept Otorhinolaryngol Head & Neck Surg, Munster, Germany
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Int Airway Res Ctr, Dept Otorhinolaryngol, Guangzhou, Peoples R China
[4] Univ Ghent, Fac Med, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium
[5] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada
[6] Univ Hosp Leuven, Dept Otorhinolaryngol, Leuven, Belgium
[7] Univ Ghent, Fac Med, Upper Airways Res Lab, Ghent, Belgium
[8] Northwestern Univ, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60610 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2023年 / 11卷 / 09期
关键词：
Chronic rhinosinusitis; Nasal polyps; Biologics; RISK-FACTORS; PREVALENCE; OMALIZUMAB; ASTHMA; INFLAMMATION; GENETICS; EFFICACY; SAFETY; STATE;
D O I：
10.1016/j.jaip.2023.04.054
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Chronic rhinosinusitis with nasal polyps affects a significant portion of the worldwide population. This illness is associated with several chronic conditions and has an important impact on patient quality of life, leading to a great societal economic burden. In recent years, biologic medications have been developed and found to be effective in the treatment of chronic rhinosinusitis with nasal polyps. This review focuses on these treatment options and their ability to improve patient outcomes, including quality of life. It also reviews available evidence with regards to patient selection, monitoring of patients after treatment initiation, and comparison of different biologics and with other treatment options such as sinus surgery. & COPY; 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:2642-51)
引用
收藏
页码：2642 / 2651
页数：10
相关论文
共 50 条
  • [41] Efficacy and Safety of Biologics in Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review
    Xu, Xiaohan
    Zhang, Kairui
    Mou, Duo
    Xie, Xiaohui
    Chang, Chun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 685 - 686
  • [42] Reserve Biologics for Chronic Rhinosinusitis with Nasal Polyps After Failed Sinus Surgery
    David Z. Allen
    Amber U. Luong
    Current Otorhinolaryngology Reports, 2023, 11 : 266 - 272
  • [43] Therapy of chronic Rhinosinusitis with Nasal Polyps KBV evaluates different Biologics as equivalent
    Klimek, Ludger
    ALLERGO JOURNAL, 2022, 31 (08) : 46 - 47
  • [44] Decision-making in the treatment of chronic rhinosinusitis with nasal polyps in the era of biologics
    Hoffmann, Anna S.
    Betz, Christian S.
    Boescke, Robert
    Weber, Rainer K.
    HNO, 2024, 72 (04) : 225 - 230
  • [45] Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
    Cai, Shiru
    Xu, Shenglong
    Lou, Hongfei
    Zhang, Luo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1876 - +
  • [46] The GALEN sinusitis cohort: impact on quality of life in patients with chronic rhinosinusitis with nasal polyps (CRSwNP)
    Khan, A.
    Vandeplas, G.
    Huynh, T. M. T.
    Mannent, L.
    Tomassen, P.
    van Zele, T.
    Cardell, L-O
    Arebro, J.
    Olze, H.
    Foerster, U.
    Kowalski, M. L.
    Olszewska-Ziazber, A.
    Fokkens, U.
    van Drunen, C.
    Mullol, J.
    Alobid, I
    Hellings, P.
    Hox, V
    Toskala, E.
    Scadding, G.
    Lund, V
    Bachert, C.
    ALLERGY, 2015, 70 : 282 - 283
  • [47] Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?
    Klimek, L.
    Foerster-Ruhrmann, U.
    Olze, H.
    Beule, A. G.
    Chaker, A.
    Hagemann, J.
    Huppertz, T.
    Hoffmann, T. K.
    Dazert, S.
    Deitmer, T.
    Strieth, S.
    Wrede, H.
    Schlenter, W.
    Welkoborsky, H. J.
    Wollenberg, B.
    Becker, S.
    Baerhold, F.
    Klimek, F.
    Casper, I.
    Zuberbier, J.
    Rudack, C.
    Cuevas, M.
    Hintschich, C. A.
    Guntinas-Lichius, O.
    Stoever, T.
    Bergmann, C.
    Werminghaus, P.
    Pfaar, O.
    Gosepath, J.
    Groeger, M.
    Beutner, C.
    Laudien, M.
    Weber, R. K.
    Hildenbrand, T.
    Hoffmann, A. S.
    Bachert, C.
    ALLERGOLOGIE, 2024, 47 (03)
  • [48] Chronic Rhinosinusitis with Nasal Polyps
    Stevens, Whitney W.
    Schleimer, Robert P.
    Kern, Robert C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (04): : 565 - +
  • [49] Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
    Borish, Larry
    Cohen, Noam A.
    Chupp, Geoffrey
    Hopkins, Claire
    Wagenmann, Martin
    Sousa, Ana R.
    Smith, Steven G.
    Silver, Jared
    Yang, Shibing
    Mayer, Bhabita
    Yancey, Steven W.
    Chan, Robert H.
    Fokkens, Wytske
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 (02) : 160 - 168
  • [50] Nasal IL-25 predicts the response to oral-corticosteroid in chronic rhinosinusitis with nasal polyps (CRSwNP)
    Hong, H.
    Chen, F.
    Sun, Y.
    Fan, Y.
    Shi, J.
    Li, H.
    ALLERGY, 2018, 73 : 248 - 249
12345